#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    T-cell type acute leukaemia Oesophageal adenocarcinoma stage III Liposarcoma Chondrosarcoma metastatic Small for dates baby Epilepsy Thyroid cancer metastatic Systemic mastocytosis Cholestatic pruritus Retinopathy proliferative Stevens-Johnson syndrome Progressive multifocal leukoencephalopathy Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Usher's syndrome Peripheral T-cell lymphoma unspecified More trials…

    Learn about Rare Diseases

    Hereditary motor and sensory neuropathy – Treatment Activated PI3 kinase delta syndrome – Life with Disease Chondrosarcoma metastatic Ehlers-Danlos syndrome – Trials in Disease Advanced systemic mastocytosis – Trials in Disease Primary biliary cholangitis Glycogen storage disease type II Mantle cell lymphoma stage III – Trials in Disease Congenital generalised lipodystrophy – Basic Information Pleomorphic leiomyosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Flutemetamol (18F) Diphenhydramine Apraglutide Levomepromazine Hydrochloride Ropivacaine Hydrochloride OMTX705 Lutropin Alfa Diazepam Telisotuzumab Vedotin Bulevirtide Rbl012.2 Ulipristal Acetate Anhydrous Azithromycin MORPHINE Sumatriptan Succinate Calcium Carbonate Bms-986340 L-Histidine Hydrochloride Letetresgene Autoleucel Bortezomib More therapies…

    Learn about Your Condition

    Arterial stiffness Acute lymphocytic leukaemia Chondropathy Mucopolysaccharidosis II Rhinitis allergic Burkitt's lymphoma Synovial sarcoma recurrent Renal injury BRAF gene mutation Cervix carcinoma recurrent Sleep disorder Corneal dystrophy Menopause Myocardial infarction Peyronie's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Acetylsalicylic Acid for Preventing Preeclampsia in Pregnant Women

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pre-eclampsia
    Investigated Drugs:
    • Acetylsalicylic Acid
    Spain
  • Pembrolizumab for Patients with Localised dMMR Colon Cancer: Neoadjuvant and Organ-Sparing Treatment Study

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Pembrolizumab
    Denmark
  • REGN10597 Alone or with Cemiplimab in Adults with Advanced Solid Tumours, Melanoma, or Clear-Cell Renal-Cell Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Clear cell renal cell carcinoma
    • Neoplasm
    Investigated Drugs:
    • Cemiplimab
    France Germany Italy Spain
  • Study to evaluate if colchicine reduces inflammation in patients with chronic coronary artery disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Myocardial ischaemia
    • Coronary artery disease
    Investigated Drugs:
    • Colchicine
    • Placebo
    Denmark
  • Daridorexant for Insomnia in Patients with Major Depressive Disorder and Moderate to Severe Insomnia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Insomnia
    • Major depression
    Investigated Drugs:
    • Magnesium Stearate
    • Cellulose, Microcrystalline
    • Daridorexant
    Spain
  • AZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • AZD0120
    • Bortezomib
    • Carfilzomib
    France Germany Italy Norway Poland Spain
Previous Page
1 … 713 714 715 716 717 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!